Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep342 | Endocrine-Related Cancer | ECE2024

Heterogeneity of responses of dynamic tests in patients with ectopic cushing’s syndrome (ECS). the half of patients with ECS have an increase in ACTH in the CRH/desmopressin test, nearly 1/3 have complete or some inhibition of cortisol in HDDST

Gamrat Aleksandra , Minasyan Mari , Aleksandra Komisarz-Calik Maria , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: According to the literature, the CRH test has the highest specificity in excluding ECS (ACTH 93.9%, cortisol 89.4%). A combination of the high dose dexamethasone test (HDDST) and CRH/desmopressin test (CRH/desmopressinT) is used to increase the discriminatory capacity in ACTH-dependent CS.Objectives: This study aims to investigate the response to dynamic tests in ECS patients.Methods: 35 consecutive ECS patients were ...

ea0099p530 | Pituitary and Neuroendocrinology | ECE2024

The analgesic effect of pasireotide in aggressive, giant pituitary neuroendocrine tumors-case series

Ciszek Karol , Bogusławska Anna , Aleksandra Komisarz-Calik Maria , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Pasireotide is a a synthetic polypeptide second-generation somatostatin analogue that can be used in the treatment of GH- and ACTH- secreting pituitary neuroendocrine tumors (PitNETs), however, there are single reports of pasireotide treatment in other subtype of PitNETs. We present a case series of aggressive, giant PitNETs treated with pasireotide alone or as multimodal therapy.Case 1: A 33-year-old male reported to the Clinic due to severe headaches a...

ea0099ep352 | Pituitary and Neuroendocrinology | ECE2024

Are giant prolactinomas different from macroprolactinomas? The single-centre observation

Aleksandra Komisarz-Calik Maria , Bogusławska Anna , Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja

Introduction: The data on giant prolactinomas (the rare (3%) subtype of lactotroph PitNET (≥40 mm) ), often causing clinical and therapeutic difficulties are scarce.Aim: We studied clinical/biochemical and treatment outcomes differences between giant and macroprolactinomas.Materials and methods: Consecutive patients with giant prolactinomas ≥40 mm (GP) and macroprolactinomas >10 mm<40 mm (MP) treated in the tert...

ea0099p311 | Endocrine-Related Cancer | ECE2024

The impact of primary tumor site on clinical manifestation and prognosis of ectopic Cushing’s syndrome (ECS). Do pulmonary neuroendocrine tumors stand out?

Gamrat Aleksandra , Minasyan Mari , Komisarz-Calik Maria Aleksandra , Rzepka Ewelina , Paleń-Tytko Joanna , Opalinska Marta , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: Ectopic Cushing’s syndrome (ECS) is a rare disease with limited and error-prone published data on the epidemiology, clinical presentation and diagnosis of ECS.Objectives: This study aims to examine the clinical course of patients with ECS in relation to the primary tumor localization.Methods: Thirty-five consecutive ECS patients at a tertiary clinical center were analyzed. The clinical, biochemical (including CRH...

ea0037ep809 | Pituitary: clinical | ECE2015

Thyrotropinoma – not just hyperthyroidism

Gurgul Edyta , Gryczynska Maria , Maciejewski Adam , Klimowicz Aleksandra , Lapinska Dagny , Ruchala Marek

Thyrotropinoma is a very rare cause of hyperthyroidism. In October 2014 a 41-year-old male patient was examined for anaemia and diarrhoea. Abdomen CT scan, gastroscopy, colonoscopy and parasite tests did not reveal any abnormalities. The patient had lost 18 kg 7 years ago and his weight had been stable since then (BMI 21.3 kg/m2). The laboratory tests revealed high TSH, normal fT4 and low cortisol level. The patient referred to our department presented wi...

ea0070aep574 | Pituitary and Neuroendocrinology | ECE2020

Cushing’s disease: Assessment of MGMT expression in pituitary corticotroph tumors and its relationship to clinical, pathological and ultrastructural parameters

Witek Przemyslaw , Maksymowicz Maria , Szamotulska Katarzyna , Stasiewicz Aleksandra , Wojciechowska-Luzniak Agnieszka , Zielinski Grzegorz

Background: O-6-Methylguanine-DNA-methyltransferase (MGMT) is a DNA repair enzyme. It has been demonstrated that its higher expression counteracts cytotoxicity of alkylating agents used in the treatment of glioblastoma or invasive pituitary tumors. Little is known on the relationships between MGMT expression and invasiveness of corticotroph adenomas in Cushing disease (CD).The Aim: To evaluate MGMT expression and its associations with clinical, neuropath...

ea0056p881 | Pituitary - Clinical | ECE2018

Subclinical left ventricular dysfunction in patients with naive acromegaly assessed by two-dimensional speckle tracking echocardiography (2D-STE)

Popielarz-Grygalewicz Agata , Ste Maria , Gesior Jakub , Konwicka Aleksandra , Grygalewicz Pawel , Zgliczynski Wojciech , Debrowski Marek

Introduction: Cardiac disease called acromegalic cardiomyopathy may be present in patients with acromegaly at diagnosis, however most echocardiographic studies showed that systolic function in these patients is normal. Speckle tracking echocardiography (STE) is a novel method that allows for the study of global longitudinal strain (GLS), a marker of early and subclinical left ventricular (LV) systolic dysfunction.Objective: To evaluate left ventricular G...

ea0070aep259 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Randomized controlled trial of different intensities of glycemic control in women with gestational diabetes

Popova Polina , Tkachuk Aleksandra , Vasukova Elena , Dronova Aleksandra , Bolotko Yana , Pustozerov Evgenii , Vasilieva Elena , Kokina Maria , Li Olga , Zazerskaya Irina , Pervunina Tatiana , Grineva Elena

Background and aims: Current glycaemic treatment targets for women with gestational diabetes (GDM) are controversial. The aim of the study was to compare the effect of different intensities of glycaemic control in pregnant women with GDM on perinatal outcomes.Materials and methods: Pregnant women in the 8th to 31st week of gestation were randomly assigned to 2 groups per target glycaemic levels: GDM1 (very tight glycaemic targets, fasting blood glucose (...

ea0041ep606 | Endocrine tumours and neoplasia | ECE2016

Novel mutations p.V220E and c.30G>T in menin gene are associated with hereditary predisposition to multiple endocrine neoplasia type 1

Ziemnicka Katarzyna , Budny Bartlomiej , Gut Pawel , Hernik Aleksandra , Leitgeber-Dominiczak Olena , Siudzinski Marcin , Gryczynska Maria , Janicki Adam , Ruchala Marek

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant condition characterized by varying combinations of endocrine tumors and commonly accompanying hyperplasia within the parathyroid gland, anterior pituitary and gastrointestinal tract. Heterozygous germline mutation of the tumor suppressor gene MEN1 is the most common cause of the disease. Molecular genetic testing of menin gene, in which mutation is known to cause MEN1 syndrome, detects pathogenic...

ea0032p748 | Obesity | ECE2013

Differences among clinical, analytical and psychological outcomes among patients with an eating disorder after bariatric surgery

Nicolau Joana , Ayala Luisa , Rivera Rosmeri , Speranskaya Aleksandra , Olivares Josefina , Gil Apolonia , Puga Maria , Fortuny Regina , Masmiquel Lluis

Introduction: Information regarding eating disorders (ED) in postsurgical outcomes after bariatric surgery (BS) is scarce.Objectives: To analyze the effect of BS on ED and to investigate if ED influence clinical, biochemical or psychological outcomes.Methods: Sixty patients (78.3%♀, age 46.35±9.89, months since BS 46.28±28.1) who underwent BS, with a minimum follow up of 12 months, were evaluated cross-sectionally. ...